Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 3 » Issue 5
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (4185)
- Volume 20, 2024 (79)
- Volume 19, 2023 (249)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Archive: Volume 3, 2007
Effect of high-dose milnacipran in patients with depression
Masatoshi Hayashi, Masaru Mimura, Tempei Otsubo, Kunitoshi Kamijima
Neuropsychiatric Disease and Treatment 2007, 3:699-702
Published Date: 15 November 2007
Gabapentin-induced coma: A MR-spectrometry analysis
Lamine Abdennour, Paola Sanchez-Peña, Damien Galanaud, Vincent Navarro, Nicolas Weiss, et al
Neuropsychiatric Disease and Treatment 2007, 3:695-698
Published Date: 15 November 2007
Complex obsessive compulsive and impulsive symptoms in Tourette’s syndrome
Donna Palumbo, Roger Kurlan
Neuropsychiatric Disease and Treatment 2007, 3:687-693
Published Date: 15 November 2007
Increase of plasma brain-derived neurotrophic factor levels in two psychotic depressed patients responding to lithium addition to paroxetine treatment
Reiji Yoshimura, Koshiro Tsuji, Nobuhisa Ueda, Jun Nakamura
Neuropsychiatric Disease and Treatment 2007, 3:683-686
Published Date: 15 November 2007
Carisoprodol withdrawal induced delirium: A case study
Karen Ni, Margaret Cary, Paul Zarkowski
Neuropsychiatric Disease and Treatment 2007, 3:679-682
Published Date: 15 November 2007
Episodic vertigo resulting from vascular risk factors, cervical spondylosis and head rotation: Two case reports
Mayowa O Owolabi, Okechukwu S Ogah, Adesola Ogunniyi
Neuropsychiatric Disease and Treatment 2007, 3:675-678
Published Date: 15 November 2007
Structural integrity of the uncinate fasciculus in geriatric depression: Relationship with age of onset
Warren D Taylor, James R MacFall, Guido Gerig, Ranga R Krishnan
Neuropsychiatric Disease and Treatment 2007, 3:669-674
Published Date: 15 November 2007
Use of fMRI to predict psychiatric adverse effects of interferon treatment for Hepatitis C – preliminary report
Donald H Marks, Mehdi Adineh, Binquan Wang, Sudeepa Gupta
Neuropsychiatric Disease and Treatment 2007, 3:655-667
Published Date: 15 November 2007
Family history, early adversity and the hypothalamic-pituitary-adrenal (HPA) axis: Mediation of the vulnerability to mood disorders
Stuart Watson, Bruce M Owen, Peter Gallagher, Andrea J Hearn, Allan H Young, et al
Neuropsychiatric Disease and Treatment 2007, 3:647-653
Published Date: 15 November 2007
The clinical differentiation of fronto-temporal dementia from psychiatric disease
Peter K Panegyres, Angela Graves, Kate AR
Neuropsychiatric Disease and Treatment 2007, 3:637-645
Published Date: 15 November 2007
Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer’s disease
Tiffany W Chow, Bruce G Pollock, Norton W Milgram
Neuropsychiatric Disease and Treatment 2007, 3:627-636
Published Date: 15 November 2007
Dementia with Lewy bodies: Definition, diagnosis, and pathogenic relationship to Alzheimer’s disease
Robert E Mrak, W Sue T Griffin
Neuropsychiatric Disease and Treatment 2007, 3:619-625
Published Date: 15 November 2007
Whole genome association studies of neuropsychiatric disease: An emerging era of collaborative genetic discovery
Margaret A Keller, Katrina Gwinn, Josefina Nash, Jonathan Horsford, Ran Zhang, et al
Neuropsychiatric Disease and Treatment 2007, 3:613-618
Published Date: 15 November 2007
The amyloid beta ion channel hypothesis of Alzheimer’s disease
Najeeb A Shirwany, Daniel Payette, Jun Xie, Qing Guo
Neuropsychiatric Disease and Treatment 2007, 3:597-612
Published Date: 15 November 2007
Late-onset Diogenes syndrome in Chinese – an elderly case series in Hong Kong
Sau Man Sandra Chan, Pui Yiu Vivian Leung, Fung Kum Helen Chiu
Neuropsychiatric Disease and Treatment 2007, 3:589-596
Published Date: 15 November 2007
Review of olanzapine in the management of bipolar disorders
Meera Narasimhan, Travis O Bruce, Prakash Masand
Neuropsychiatric Disease and Treatment 2007, 3:579-587
Published Date: 15 November 2007
Progress update: Pharmacological treatment of Alzheimer’s disease
David B Hogan
Neuropsychiatric Disease and Treatment 2007, 3:569-578
Published Date: 15 November 2007
Sleep deprivation: Impact on cognitive performance
Paula Alhola, Päivi Polo-Kantola
Neuropsychiatric Disease and Treatment 2007, 3:553-567
Published Date: 15 November 2007
Tetrabenazine in the treatment of Huntington’s disease
Diana Paleacu
Neuropsychiatric Disease and Treatment 2007, 3:545-551
Published Date: 15 November 2007
Update on the management of neuromuscular block: focus on sugammadex
Hans D de Boer, Jan van Egmond, Jacques J Driessen, Leo HD Booij
Neuropsychiatric Disease and Treatment 2007, 3:539-544
Published Date: 15 November 2007
Transdermal selegiline for the treatment of major depressive disorder
Kelly C Lee, Jack J Chen
Neuropsychiatric Disease and Treatment 2007, 3:527-537
Published Date: 15 November 2007
Zolpidem modified-release in insomnia
Cynthia Kirkwood, Jason Neill, Ericka Breden
Neuropsychiatric Disease and Treatment 2007, 3:521-526
Published Date: 15 November 2007
Editorial Foreword: New antidepressants or more of the same? || FREE PAPER ||
Roger M Pinder
Neuropsychiatric Disease and Treatment 2007, 3:519-520
Published Date: 15 November 2007